Skip to main content
Bruce Yankner, MD, Neurology, Boston, MA

BruceAYanknerMD

Neurology • Boston, MA

Professor of Genetics and Neurology, Harvard Medical School. Director of the Harvard Neurodegeneration Training Program. Co-Director of the Paul F. Glenn Center for the Biology of Aging.

Join to view full profile

Are you Dr. Yankner?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 35 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Bruce Yankner, MD is a board certified neurologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and California. He is a Professor of Genetics and Neurology at Harvard Medical School. Director of the Harvard Neurodegeneration Training Program. Co-Director of the Paul F. Glenn Center for the Biology of Aging..

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1984 - 1986
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1982 - 1984
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1983 - Present
  • MA State Medical License
    MA State Medical License 1987 - 2025
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Press Mentions

  • What Happens to the Brain After Age 40?
    What Happens to the Brain After Age 40?November 1st, 2022
  • To Learn More Quickly, Brain Cells Break Their DNA
    To Learn More Quickly, Brain Cells Break Their DNASeptember 5th, 2021
  • Wednesday Round up #32
    Wednesday Round up #32January 14th, 2021
  • Join now to see all

Grant Support

  • Training In The Molecular Biology Of NeurodegenerationNational Institute On Aging2001–2012
  • Modeling The Aging EpigenomeOffice Of The Director, National Institutes Of Health2010–2011
  • Epigenetic Analysis Of IPS Cell Models Of Aging And Alzheimer'S DiseaseNational Institute On Aging2009–2010
  • The Role Of CDK5 In The DNA Damage Responce During Aging And NeurodegenerationNational Institute On Aging2006–2010
  • DNA Damage And Neurodegeneration In The Aging BrainNational Institute On Aging2006–2010
  • Genomic Analysis Of Human Aging And Cognitive DeclineNational Institute On Aging2007–2009
  • Gene Regulation And DNA Damage In The Aging BrainNational Institute On Aging2006–2009
  • Studies On The Mechanism Of Beta Amyloid NeurotoxicityNational Institute Of Neurological Disorders And Stroke2006–2007
  • Genomic Analysis Of Human Aging And Cognitive DeclineNational Institute On Aging2006
  • Gene Regulation And DNA Damage In The Aging BrainNational Institute On Aging2005
  • Studies On The Mechanism Of Beta Amyloid NeurotoxicityNational Institute Of Neurological Disorders And Stroke2003–2005
  • Regulation Of Amyloid Beta Protein By APOE &CholesterolNational Institute On Aging2000–2004
  • Regulation Of The App/Notch Gamma SecretaseNational Institute On Aging2000–2003
  • Mechanism Of Beta Amyloid NeurotoxicityNational Institute Of Neurological Disorders And Stroke1992–2001
  • Mechanisms Of Neuronal Degeneration In Downs SyndromeNational Institute Of Neurological Disorders And Stroke1996–1998
  • Conference On Molecular Mechanisms In Alzheimers DiseaseNational Institute On Aging1997
  • Amyloid Neurotoxicity And Biological FunctionNational Institute On Aging1990–1994
  • Gene Therapy In The Nervous System Using RetrovirusesNational Institute Of Neurological Disorders And Stroke1987–1991

Dr. Bruce Yankner, Dr. Bruce Yankner, MD, Dr. B Yankner, Dr. Bruce A Yankner